Indoor Air Pollution and Outcomes in Cystic Fibrosis
Indoor Air Pollution and Outcomes in Cystic Fibrosis
批准号:
10065102
负责人:
Sara Weller Carson
金额:
$8.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-02 至 2021-07-01
关键词:
AdolescentAdultAffectAirAsthmaBacterial InfectionsBiometryCaliberCessation of lifeChildChronicChronic Obstructive Airway DiseaseClinic VisitsClinicalClinical ResearchCommunitiesCookstoveCystic FibrosisDataData AnalysesDiseaseEnvironmentEnvironmental ExposureEnvironmental HealthExposure toForced expiratory volume functionFoundationsFutureGeneticGenetic DiseasesHome environmentHospitalizationImmersionIndividualIndoor Air PollutionIndoor environmentIntervention StudiesLife ExpectancyLungLung TransplantationLung diseasesMeasuresMonitorMorbidity - disease rateNicotineNitrogen DioxideObstructive Lung DiseasesOutcomeOzoneParticulate MatterPatient Self-ReportPatientsPilot ProjectsPopulationPseudomonas aeruginosaPublic HealthPulmonary Function Test/Forced Expiratory Volume 1QuestionnairesResearchResearch DesignRespiratory Signs and SymptomsRespiratory physiologySeasonsSiblingsSourceSpirometrySurveysTimeTobacco smokeTrainingTwin Multiple BirthUnited StatesVariantWood stoveambient air pollutionbasecatalystcoarse particlescohortcystic fibrosis patientsdata managementdiariesenvironmental tobacco smokeexperienceimprovedmethicillin resistant Staphylococcus aureusmortalitynon-geneticprematureprospectiverecessive genetic traitrespiratorysurvival prediction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Cystic Fibrosis (CF) is a lethal autosomal recessive disease affecting nearly 80,000 people worldwide. Despite
advances in therapy, CF remains a progressive lung disease that leads to decline in lung function and frequent
pulmonary exacerbations.
Higher levels of outdoor air pollution, including particulate matter (PM) with a diameter of 10µm or less (PMR10R)
and 2.5µm or less (PMR2.5R), nitrogen dioxide (NOR2R), and ozone, have been shown to lead to worse CF
outcomes such as decline in lung function and increased pulmonary exacerbations. Many studies have shown
that higher levels of indoor air pollution increase morbidity in obstructive lung diseases such as asthma and
COPD. To our knowledge, this has not been studied in individuals with CF, also an obstructive lung disease.
In this proposal we aim to study how indoor air pollution affects individuals with CF. We hypothesize that
higher levels of indoor air pollution are associated with worse CF outcomes, such as increased respiratory
symptoms and decline in lung function.
To explore our hypothesis, we will conduct a sub-analysis from data collected in the US CF Twin and Sibling
Study, which includes data on exposure to sources of indoor air pollution and clinical outcomes on over 2000
CF individuals from 2000-13. Next, we will distribute a survey to our local CF cohort to gather more detailed
home exposure data and follow respiratory symptoms and lung function over time. Finally, we will conduct a
pilot study to measure daily PMR2.5R and weekly NOR2R and nicotineR Rlevels inside the homes of 20 patients with CF
for two one-week periods, separated by season, and ask patients to answer a daily respiratory symptoms
questionnaire, complete daily activity diaries, and perform daily home spirometry. We will then determine if
daily variations in PMR2.5 Rand weekly levels of NOR2R and nicotine are associated with daily variation in respiratory
symptoms and lung function.
The research carried out in this proposal is of public health significance and will provide new information on
how indoor air pollution affects CF. The results of this study may impact the entire CF community and will
serve as a catalyst for a future, multi-center and interventional study which will be the basis for my K23
application.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jcf.2021.08.015
发表时间:
2022-03
期刊:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
影响因子:
--
作者:
[Carson SW, Psoter K, Koehler K, Siklosi KR, Montemayor K, Toporek A, West NE, Lechtzin N, Hansel NN, Collaco JM, Merlo CA]
通讯作者:
Merlo CA
海外基金